Literature DB >> 12011043

The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity.

Larry S Tobacman1, Mahta Nihli, Carol Butters, Mark Heller, Victoria Hatch, Roger Craig, William Lehman, Earl Homsher.   

Abstract

In cardiac and skeletal muscles tropomyosin binds to the actin outer domain in the absence of Ca(2+), and in this position tropomyosin inhibits muscle contraction by interfering sterically with myosin-actin binding. The globular domain of troponin is believed to produce this B-state of the thin filament (Lehman, W., Hatch, V., Korman, V. L., Rosol, M., Thomas, L. T., Maytum, R., Geeves, M. A., Van Eyk, J. E., Tobacman, L. S., and Craig, R. (2000) J. Mol. Biol. 302, 593-606) via troponin I-actin interactions that constrain the tropomyosin. The present study shows that the B-state can be promoted independently by the elongated tail region of troponin (the NH(2) terminus (TnT-(1-153)) of cardiac troponin T). In the absence of the troponin globular domain, TnT-(1-153) markedly inhibited both myosin S1-actin-tropomyosin MgATPase activity and (at low S1 concentrations) myosin S1-ADP binding to the thin filament. Similarly, TnT-(1-153) increased the concentration of heavy meromyosin required to support in vitro sliding of thin filaments. Electron microscopy and three-dimensional reconstruction of thin filaments containing TnT-(1-153) and either cardiac or skeletal muscle tropomyosin showed that tropomyosin was in the B-state in the complete absence of troponin I. All of these results indicate that portions of the troponin tail domain, and not only troponin I, contribute to the positioning of tropomyosin on the actin outer domain, thereby inhibiting muscle contraction in the absence of Ca(2+).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011043     DOI: 10.1074/jbc.M201768200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Phosphorylation, but not alternative splicing or proteolytic degradation, is conserved in human and mouse cardiac troponin T.

Authors:  Jiang Zhang; Han Zhang; Serife Ayaz-Guner; Yi-Chen Chen; Xintong Dong; Qingge Xu; Ying Ge
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

2.  Regulatory proteins alter nucleotide binding to acto-myosin of sliding filaments in motility assays.

Authors:  E Homsher; M Nili; I Y Chen; L S Tobacman
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

Review 3.  Structural based insights into the role of troponin in cardiac muscle pathophysiology.

Authors:  Monica X Li; Xu Wang; Brian D Sykes
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

4.  Structure of the mid-region of tropomyosin: bending and binding sites for actin.

Authors:  Jerry H Brown; Zhaocai Zhou; Ludmilla Reshetnikova; Howard Robinson; Rama D Yammani; Larry S Tobacman; Carolyn Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

5.  Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

Authors:  Briar R Ertz-Berger; Huamei He; Candice Dowell; Stephen M Factor; Todd E Haim; Sara Nunez; Steven D Schwartz; Joanne S Ingwall; Jil C Tardiff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

Review 6.  Energy metabolism in heart failure and remodelling.

Authors:  Joanne S Ingwall
Journal:  Cardiovasc Res       Date:  2008-11-05       Impact factor: 10.787

7.  Interplay between the overlapping ends of tropomyosin and the N terminus of cardiac troponin T affects tropomyosin states on actin.

Authors:  Ranganath Mamidi; John Jeshurun Michael; Mariappan Muthuchamy; Murali Chandra
Journal:  FASEB J       Date:  2013-06-07       Impact factor: 5.191

8.  A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.

Authors:  K M Broughton; J Li; E Sarmah; C M Warren; Y-H Lin; M P Henze; V Sanchez-Freire; R J Solaro; B Russell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

9.  Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific.

Authors:  Huamei He; Kirsten Hoyer; Hai Tao; Ronald Rice; Jesus Jimenez; Jil C Tardiff; Joanne S Ingwall
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

10.  Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy.

Authors:  Mark Luedde; Ulrich Flögel; Maike Knorr; Christina Grundt; Hans-Joerg Hippe; Benedikt Brors; Derk Frank; Uta Haselmann; Claude Antony; Mirko Voelkers; Juergen Schrader; Patrick Most; Bjoern Lemmer; Hugo A Katus; Norbert Frey
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.